Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07578363 · ClinicalTrials.gov registry record · Phase 3
An Investigation of FID 123472 Ophthalmic Solution to Vehicle for the Reduction of Ocular Redness in Adults
A Phase 3 study, sponsored by Alcon Research.
- Not yet
- Registry status
- Phase 3
- Development phase
- 178
- Enrollment target
NCT07578363: Clinical Trial Phase 3 study, sponsored by Alcon Research.
NCT07578363 is a Phase 3 study that has not yet begun recruiting, run by Alcon Research. The registered enrollment target is 178 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07578363, a Phase 3 study, has not yet begun recruiting, sponsored by Alcon Research.
- NOT YET RECRUITING
- Registry status
- Phase 3
- Development phase
- 178 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the efficacy and safety of an investigational ophthalmic solution in adults with ocular redness caused by minor eye irritations.
Primary Outcome
Ocular redness will be assessed by the investigator and recorded per the Ora Calibra® Ocular Hyperemia Scale, which ranges from 0 to 4 in half-point increments (0.0 = none; 1.0 = mild redness; 2.0 = moderate redness; 3.0 = severe redness; and 4.0 = extremely severe redness). Change from baseline, calculated as post-instillation minus baseline score, can range between -4 and +2.5. Positive values indicate increased ocular redness (worsening), zero indicates no change, and negative values indicate
Interventions
- DRUG Vehicle
- DRUG Apraclonidine Ophthalmic Solution, 0.125% Unit Dose Preservative Free
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 178 participants |
| Start Date | 2026-09 |
| Est. Completion | 2027-03 |
| Phase | Phase 3 |
What is known before NCT07578363 opens enrollment
NCT07578363 is an interventional study that assigns participants to a tested intervention. The registered 178 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (77% lower).
The record links to 0 conditions, and to 2 interventions - of which Vehicle is the first listed.
NCT07578363 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07578363 about?
NCT07578363 is a clinical study titled "An Investigation of FID 123472 Ophthalmic Solution to Vehicle for the Reduction of Ocular Redness in Adults". The purpose of this study is to evaluate the efficacy and safety of an investigational ophthalmic solution in adults with ocular redness caused by minor eye irritations.
What is the current status of trial NCT07578363?
This trial is currently not yet recruiting. It is a Phase 3 study. The enrollment target is 178 participants. The study started on 2026-09. Estimated completion is 2027-03.
What interventions are being tested in trial NCT07578363?
The interventions under investigation include: Vehicle (DRUG), Apraclonidine Ophthalmic Solution, 0.125% Unit Dose Preservative Free (DRUG).
Who is sponsoring clinical trial NCT07578363?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07578363's enrollment target sits among peer trials
178 1437th of 2000 higher than 563 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03642002 · 178 participants · NA
The Effects of Music Therapy on Adult Patients Requiring Mechanical Ventilation in the ICU
- NCT04227847 · 178 participants · Phase 1
A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies
- NCT04855214 · 178 participants
Evaluating the Experience of Upper Limb Prosthesis Use
- NCT05391126 · 178 participants · NA
GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia